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ABSTRACT 20 
Lumbar muscle degeneration is a common feature in non-specific low back pain (LBP). 21 
It is hypothesized that degenerated muscles might compromise spinal stability and 22 
lead to further injury/pain. However, little is known about lumbar muscle 23 
morphometry after resolution of LBP. Therefore, this study investigated the extent of 24 
lumbar muscle atrophy and fatty infiltration in individuals who are at risk for a 25 
recurrence of LBP. Thirteen participants in remission of unilateral recurrent LBP were 26 
compared to 13 healthy controls, comparable for age, weight, length and level of 27 
physical activity. Total, lean muscle and fat cross-sectional area (CSA) of lumbar 28 
multifidus (MF), erector spinae (ES) and psoas (PS) were investigated on T1-weighted 29 
Magnetic Resonance Imaging (MRI), bilaterally and at 3 lumbar levels (L3 upper, L4 30 
upper and L4 lower endplate). In addition, a muscle-fat-index (MFI) was calculated 31 
reflecting the amount of fatty infiltration in lean muscle tissue. No significant 32 
differences for total, lean muscle and fat CSA were found between people in remission 33 
of recurrent LBP and the control group. Conversely, MFI was increased bilaterally at 34 
the 2 lowest lumbar levels. There were no differences between the previously painful 35 
and non-painful side of the LBP group for any of the parameters. These results show a 36 
generalized increase in intramuscular fatty infiltration in lean muscle tissue in the 37 
absence of macroscopical signs of muscle degeneration after resolution of LBP. These 38 
findings reflect a decreased muscle quality, but not quantity, and might indicate a 39 
pathophysiological mechanism contributing to recurrence of LBP. 40 
 41 
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INTRODUCTION 44 
Lumbar muscle degeneration is a common feature in non-specific low back pain (LBP) 45 
and is macroscopically characterized by decreased muscle size (atrophy) and increased 46 
fat deposition (Parkkola et al., 1993;Danneels et al., 2000). Lumbar muscle degeneration 47 
may compromise spinal stability and jeopardize spinal health, potentially leading to 48 
further injury/LBP (Panjabi, 1992). Consequently, lumbar muscle morphometry has 49 
been investigated increasingly as a biomarker of LBP. 50 
Atrophy of the paraspinal muscles (especially multifidus [MF]) has been consistently 51 
demonstrated with LBP (Hultman et al., 1993;Hides et al., 1994;Danneels et al., 52 
2000;Hides et al., 2008;Wallwork et al., 2008), and is often accompanied by reduced 53 
cross-sectional area (CSA) of the psoas (PS) muscle (Parkkola et al., 1993;Kamaz et al., 54 
2007). With unilateral LBP distribution, atrophy of MF (Hyun et al., 2007;Hides et al., 55 
2008;Kim et al., 2011) and PS (Barker et al., 2004;Ploumis et al., 2010) was more 56 
pronounced on the painful compared to the non-painful side. Results on fatty 57 
infiltration in relation to LBP are variable with fatty infiltrates observed in some 58 
studies (Hultman et al., 1993;Parkkola et al., 1993;Mengiardi, 2006;Kjaer et al., 2007), 59 
but not others (McLoughlin et al., 1994;Danneels et al., 2000;Kjaer et al., 2007). 60 
Little however is known about lumbar muscle morphometry in individuals with a 61 
history of LBP but without current pain. Lumbar muscle degeneration after a LBP 62 
episode may be a pathophysiological mechanism for LBP recurrence. Hultman et al. 63 
(1993) found no differences in paraspinal CSA or density (=substitute for fatty 64 
infiltration) on CT (Computed Tomography) during remission of intermittent LBP 65 
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compared to healthy controls. Hides et al. (1996) prospectively investigated MF 66 
asymmetry between painful and non-painful sides during resolution of unilateral LBP 67 
using ultrasound: MF atrophy on the painful side did not recover automatically. 68 
Further research is warranted to characterize lumbar muscle degeneration during 69 
remission of LBP, when people are at risk of recurrent episodes. 70 
Typically, lumbar muscle size (CSA) is measured by outlining fascial muscle borders 71 
on axial images (Hu et al., 2011), however, CSA measures may be distorted by 72 
replacement of muscle with adipose or connective tissue (Parkkola et al., 73 
1993;Ropponen et al., 2008). Fat deposition is usually estimated qualitatively using 74 
visual grading systems (Kader et al., 2000;Ropponen et al., 2008), but these potentially 75 
overlook small changes in muscle composition (Mengiardi, 2006;Lee et al., 2008). 76 
Another approach is to distinguish muscle and fat tissue quantitatively (Ropponen et 77 
al., 2008;Hu et al., 2011). In that context, Magnetic Resonance Imaging (MRI) is 78 
prefered over CT, due to superior spatial resolution and distinguishing features of soft 79 
tissues without radiation exposure (Hu et al., 2011). A histographic method has been 80 
proven effective to separate muscle from clearly visible fat depositions based on 81 
differences in pixel signal intensity (SI)(Hyun et al., 2007;Lee et al., 2008;Min et al., 82 
2009). The muscle-fat-index (MFI) is another method for interindividual comparison of 83 
intramuscular fatty infiltration, involving the calculation of the ratio of the mean SI in a 84 
region of muscle tissue relative to the SI in a homogenous region of fat (Elliott et al., 85 
2005;Elliott et al., 2008b;Cagnie et al., 2009;Elliott et al., 2010).  86 
Combining the measures total, lean muscle and fat CSA and MFI with MRI provides a 87 
quantitative and multifaceted view, to investigate whether lumbar muscle 88 
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morphometry and composition differs during remission of unilateral recurrent LBP 89 
compared to a healthy control group, and whether this is pain-side related. We 90 
hypothezised that lumbar muscle degeneration would be present in participants with a 91 
history of LBP, and being most prominent on the previously painful side. 92 
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METHODS 93 
Participants 94 
Thirteen individuals with recurrent non-specific LBP were recruited via advertisement 95 
in the local community and university. Inclusion criteria were a history of at least 2 96 
previous episodes of LBP (onset >6 months) that interfered with activities of daily 97 
living and/or required treatment (LBP characteristics: Table 1). Episodes were defined 98 
as bouts of LBP for a minimum of 24 hours, preceded and followed by a period of 99 
minimum 1 month without symptoms (de Vet et al., 2002). Testing was scheduled at 100 
least 1 month after the end of the previous episode (time since last episode: 64±33,6 101 
days). 102 
Thirteen individuals without a history of LBP, comparable for gender, age, weight, 103 
length and level of physical activity, formed a healthy control group (demographic 104 
characteristics: Table 2). 105 
Participants were excluded from either group if they reported: central, bilateral or 106 
variable localization of LBP; pain elsewhere in the body; lumbar muscle training in the 107 
past year; spinal deformities or surgery; task-limiting medical conditions or contra-108 
indications for MRI. 109 
After notification of the study procedures, which were approved by the local Ethics 110 
Committee, participants provided written informed consent.  111 
Imaging procedures 112 
T1-weighted images were acquired using a 3-Tesla MRI-scanner (Magnetom Trio-Tim, 113 
SyngoMR VB15 software, Siemens AG®, Erlangen Germany). Participants were placed 114 
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supine with a foam wedge supporting the legs (~30° hip flexion). A flexible 6-element 115 
body-matrix coil, centered ventrally on L4, was combined with the standard phased-116 
array spine coil dorsally as a receiver-coil combination. 117 
On a sagittal localizing scan, 3 slices were positioned as axially as possible along the 118 
upper endplate of L3 and L4 and lower endplate of L4, visualizing lumbar MF, erector 119 
spinae (ES) and PS. These levels were selected as paraspinal and PS muscle mass is at 120 
or near maximal, enhancing the possibility to demonstrate CSA differences (Danneels 121 
et al., 2000;Lee et al., 2008). Level L4 lower endplate was used as a substitute for L5, 122 
because the inclination of L5 is often too large to visualize the muscles’ cross-section 123 
appropriately. 124 
A spin-echo (SE) sequence was used: repetition time (TR) 550ms, echo time (TE) 9ms, 125 
acquisition matrix 384*258mm², flip angle 75°, field of view (FOV) 340mm, voxel size 126 
0.9*0.9*4mm², scan time 4min45s. 127 
Data analysis 128 
MRI-data were analyzed using Image J (Java-based version of the public domain NIH 129 
Image Software; Research Services Branch), blind to the participants’ LBP history. MF, 130 
ES and PS were bilaterally outlined at each level (=total muscle region of interest 131 
[ROI])(Fig. 1). Each ROI was then segmented based on differences in SI between fat 132 
and muscle tissue. Using a histogram showing the SI distribution, pixels with high SI 133 
(fat) were eliminated. From the remaining pixels (=lean muscle ROI)(Fig. 1), the mean 134 
SI was calculated. Total and lean muscle CSA (mm²) were calculated as the number of 135 
pixels in the respective ROI multiplied by the pixel size. Fat CSA was calculated as the 136 
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difference between total and lean muscle CSA. All CSAs were normalized to the 137 
vertebral body at the L4 upper endplate (Danneels et al., 2000). 138 
Finally, the mean SI was calculated in a homogenous region of fat (lateral corner 139 
between right ES and quadratus lumborum). MFI was calculated by dividing the mean 140 
SI of the lean muscle ROI by the fat ROI (Elliott et al., 2005). Quantitative evaluation of 141 
paraspinal muscle composition on MRI has been proven highly reliable (Ropponen et 142 
al., 2008;Hu et al., 2011). 143 
Statistical analysis 144 
Statistical analyses were carried out using IBM SPSS Statistics 19.  145 
Descriptive statistics were calculated for participant and LBP characteristics. Between-146 
group comparisons were tested using independent samples t-tests.  147 
Total and lean muscle CSA, fat CSA and MFI were compared 1) between LBP and 148 
healthy control group (Group) and 2) between sides within the LBP group (Pain side) 149 
using linear mixed model analysis. These mixed models account for correlated 150 
measures by including a random intercept for participants, and adjust for Muscle (MF, 151 
ES, PS), Level (L3upper, L4upper, L4lower) and Body Side (left, right). Parameter 152 
estimation was done by restricted maximum likelihood. As differences between body 153 
sides, levels or muscles were not our main research questions, only main/interaction 154 
effects for Group and Pain side are presented. To rule out a possible influence of hand 155 
dominance, two left-handed participants were omitted from the mixed model analysis 156 
(11P-13C).  157 
The association between CSA and MFI versus demographic and LBP variables was 158 
evaluated using Pearson’s correlation coefficients. 159 
10 
 
Post-hoc comparisons were made when required and were adjusted using Bonferroni-160 
correction. Statistical significance was set at α=0.05. 161 
11 
 
RESULTS 162 
Differences between LBP and control group 163 
For total muscle CSA, there was an interaction between Group and Muscle (p=0.001). 164 
Post-hoc tests for individual muscles, revealed no group differences for any muscles at 165 
any levels (MF P=0.337; ES P=0.627; PS P=0.339)(Fig. 2, Table 3).  166 
Similarly, there were no group differences for any muscles at any levels for lean muscle 167 
CSA (interaction Group*Muscle: p=0.001, Post hoc: MF P=0.276; ES P=0.752; PS 168 
P=0.342)(Fig. 2, Table 3). 169 
There were no differences in fat CSA between the LBP and control group (main effect 170 
Group: p=0.640)(Fig. 2, Table 3). 171 
MFI (interaction Group*Level: p=0.005) was higher in the LBP compared to the control 172 
group for all muscles at L4upper (P=0.014) and L4lower (P=0.017), but not at L3upper 173 
(P=0.380)(Fig. 3, Table 3). 174 
Differences between previously painful and non-painful sides in the LBP group 175 
There were no pain-side related differences in the LBP group for any muscles at any 176 
levels (Table 4): total and lean muscle CSA, fat CSA (Main effect Pain side respectively 177 
p=0.581; p=0.418; p=0.353), and MFI (Interaction effect Muscle*Pain side: p<0.001; Post 178 
Hoc: MF P=0.932; ES P=0.153; PS P=0.585). 179 
Correlations  180 
With regard to demographic characteristics, total and lean CSA correlated (p<0.05) 181 
with weight (respectively r=0.578; r=0.529), length (respectively r=0.503; r=0.454) and 182 
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body mass index (BMI)(respectively r=0.496; r=0.456). MFI correlated with weight 183 
(r=0.509, p=0.013) and BMI (r=0.553, p=0.006). 184 
Analysis of LBP characteristics showed that MFI correlated with the frequency of 185 
episodes (r=0.671, p=0.034) and lean and total CSA were associated with the elapsed 186 
time since the last episode (respectively r=0.789, p=0.035; r=0.800, p=0.031).  187 
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DISCUSSION 188 
This study investigated whether lumbar muscle degeneration was present during 189 
remission of unilateral recurrent LBP. In contrast to our hypothesis, there were no 190 
differences in total, lean muscle or fat CSA from the control group, or pain-side related 191 
differences in the LBP group. Conversely, MFI was higher in the LBP group for all 192 
muscles (MF, ES, PS), without any pain-side related differences. 193 
 194 
There were no group or pain-side related differences in muscle size for any muscles. 195 
The lack of group differences in the current study supports the results of Hultman et al. 196 
(1993), who showed no alterations in paraspinal (MF+ES) muscle CSA at L3 during 197 
remission of intermittent LBP. The lack of side differences in CSA differs however with 198 
the results of Hides et al. (1996), who reported ongoing MF atrophy on the painful side 199 
despite LBP resolution. This discrepancy may be related to methodological differences. 200 
First, in the study of Hides et al. MF CSA asymmetry was localized to the symptomatic 201 
level, while it was symmetric at the neighboring asymptomatic levels. In our study, the 202 
symptomatic level could not be evaluated because the population was recruited in 203 
remission of LBP. Moreover, MF asymmetry was principally reported at L5 and our 204 
study did not measure below the L4 lower endplate. In addition, measuring methods 205 
differed, ultrasound vs. MRI. Although these techniques previously yielded similar 206 
results for lumbar muscle CSA, it has not been demonstrated whether this holds in 207 
fatty infiltrated muscles (Hides et al., 1995). Finally, lumbar muscle size during 208 
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recovery of LBP was not directly compared to a control group (Hides et al., 1996), 209 
therefore group differences cannot be discussed. 210 
Unlike other studies reporting atrophy during LBP (Parkkola et al., 1993;Hides et al., 211 
1994;Danneels et al., 2000;Barker et al., 2004), we were not able to reveal differences in 212 
total or lean muscle CSA during remission of recurrent LBP. We speculate that muscle 213 
size was not reduced, or, had recovered in this specific population. Support for 214 
recovery from atrophy is provided by associations showing that 62 and 64% (R²=0.623; 215 
R²=0.640) of the variance in lean and total CSA, respectively, can be explained by the 216 
time elapsed between testing and previous LBP episode (mean: 64, min: 31, max: 144 217 
days). This finding appears in contrast to Hides et al. (1996), who observed no 218 
alteration in localized MF asymmetry after about 42 pain-free days. In addition to the 219 
methodological differences discussed above, our association was irrespective of pain 220 
side, muscle or level and observed in a wider timeframe. Further longitudinal research 221 
of the natural course of lumbar muscle morphometry during resolution of LBP is 222 
needed. 223 
Below, several hypotheses for decreased lumbar muscle size in relation to LBP are 224 
discussed in view of our lack of atrophy during remission of LBP. First, atrophy may 225 
result from muscular disuse e.g. general deconditioning and local disuse (altered 226 
recruitment)(Hides et al., 1994;Danneels et al., 2000;Hodges et al., 2006). With regard to 227 
conditioning status, both groups had similar scores for physical activity, comparable to 228 
scores from young adults (Baecke et al., 1982). Altered recruitment of muscles cannot 229 
be discounted as there is evidence for decreased (Macdonald et al., 2009), unchanged 230 
(Macdonald et al., 2010) and increased (Macdonald et al., 2011;D'Hooge et al., 2012a) 231 
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MF recruitment during remission of recurrent LBP. Second, experimentally-induced 232 
spinal injury (disc and nerve root lesion) has been shown to cause specific patterns of 233 
muscle wasting in the porcine MF within 3 days of the lesion (Hodges et al., 2006). It is 234 
not known what muscular replications can particularly be expected from non-specific 235 
LBP, 64 days at average after LBP resolution. Third, if peripheral nociception would 236 
reduce muscle CSA directly, this could contribute to marked differences observed 237 
during LBP compared to less conclusive evidence during LBP remission. Further 238 
research that investigates the isolated effect of nociception on lumbar muscle size may 239 
be able to confirm this hypothesis. 240 
 241 
MFIs in lean muscle tissue were increased during remission of LBP, which reflects 242 
increased relative amounts of intramuscular lipids (Elliott et al., 2010). The extent of 243 
lean fatty infiltration was generalized rather than localized (multiple muscles and 244 
levels, both previously painful and non-painful sides). 245 
The main causes of fatty infiltration are muscular disuse and spinal injury, similar to 246 
the causes of atrophy (Elliott et al., 2006;Hodges et al., 2006). Although the generalized 247 
effect in MFI appears in favour of the deconditioning-hypothesis, this is not supported 248 
by similar scores for physical activity in both groups. Further, because paraspinal and 249 
PS muscles have different nerve supplies (dorsal vs. ventral rami of lumbar nerves, 250 
respectively) and MFI is increased bilaterally, denervation is not considered a plausible 251 
explanation in the current study. Finally, the positive correlation between fatty 252 
infiltration and episode frequency (mean: 4.4, min: 2, max: 9 per year; R²=0.450), may 253 
suggest a role for nociception in fatty infiltration. This assumption is consistent with 254 
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previous observations of generalized inhibition of MF, ES and PS recruitment with 255 
experimentally-induced pain (Dickx et al., 2008;D'Hooge et al., 2012b). Further research 256 
is required to determine if peripheral nociception is involved in fatty infiltration via a 257 
reflex-mediated decrease in neural drive. 258 
Previously, Hultman et al. (1993) found no difference in paraspinal muscle density on 259 
CT during remission of intermittent LBP. Results of fatty infiltration in the presence of 260 
LBP are less consistent than CSA measures. Some authors demonstrate increased fatty 261 
infiltration (Parkkola et al., 1993;Mengiardi, 2006;Kjaer et al., 2007; Hultman et al., 262 
1993), whereas others show no difference to healthy controls (McLoughlin et al., 263 
1994;Danneels et al., 2000;Kjaer et al., 2007). The discrepancy in results may be due to 264 
methodological differences such as the ROI in which fatty infiltration is determined 265 
(total vs. lean muscle, isolated MF vs. paraspinals grouped) or measuring technique 266 
(qualitative vs. quantitative, CT vs. MRI). The current study measured fatty infiltration 267 
in two complementary modes yielding divergent results: lean fatty infiltration was 268 
increased, without macroscopic alterations. Similarly, Mengiardi et al. (2006) revealed 269 
increased metabolic fat content with proton MR spectrocoscopy, which was not 270 
detectable with a semi-quantitative visual grading system using conventional MRI. 271 
 272 
Using a multifaceted approach to investigate lumbar muscle structure, the current 273 
study showed that fatty infiltration in lean muscle tissue was increased, without 274 
alterations in muscle size or macroscopic fat deposition during remission of LBP. This 275 
emphasises the importance of differentiating muscle quantity (CSA) and quality 276 
(composition). In this respect, Elliott et al. reported enlarged cervical muscle CSAs and 277 
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fatty infiltration in relation to whiplash-associated disorders, acknowledging that 278 
caution must be exercised during interpretation of CSA measurements in the presence 279 
of intramuscular fat (Elliott et al., 2008a;Elliott et al., 2010). Similarly, lean fatty 280 
infiltration may be masking a reduction in muscle size in our results.  281 
It is assumed that fatty infiltration may negatively affect muscle contractility when 282 
muscle fibers are replaced with non-contractile tissue. Consequently, the deteriorated 283 
muscle composition may contribute to LBP recurrence. This adds to the existing 284 
evidence of lumbar muscle dysfunction during remission of recurrent LBP (Macdonald 285 
et al., 2009-2010-2011;D'Hooge et al., 2012a). 286 
 287 
There are some limitations to this study. The absence of differences in CSA between 288 
groups or sides may be related to small participant numbers. Further studies with 289 
larger sample size are required to confirm our findings. The MFI has not previously 290 
been applied in the lumbar region. The index has been used extensively in the cervical 291 
spine (Elliott et al., 2005;Elliott et al., 2006). Unlike the cervical region, the fat ROI could 292 
not be drawn in a clear intermuscular fat area, but instead, peripherally from the 293 
lumbar muscles. This yielded comparable but slightly lower indices (range: 0.15-0.30), 294 
which might be due to calculating the MFI after segmentation of visible fat.  295 
 296 
In conclusion, the current study shows a generalized increase in fatty infiltration in 297 
lean lumbar muscle tissue, in the absence of alterations in muscle size or macroscopic 298 
fat deposition after resolution of LBP. It is hypothesized that decreased muscle quality 299 
may contribute to recurrence of LBP. 300 
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TABLES 407 
Table 1: LBP characteristics (Mean ± SD) 408 
Variable 
Duration since first onset LBP (months) 109 ± 70 
Frequency of episodes (per year) 4.4 ± 2.0 
Duration of episode (days) 5.5 ± 3.7 
Pain intensity during episode (NRS, 0-100) 57.4 ± 12.7 
Disability during episode (NRS, 0-100) 45.8 ± 21.0 
SD – standard deviation 
LBP – low back pain 
NRS – numeric rating scale 
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Table 2: Participant demographics (Mean ± SD) 409 
Variable LBP group Control group p-value 
n 13 13 - 
Male : female 6 : 7 6 : 7 - 
Age (years) 32.09 ± 11.52 32.13 ± 10.57 0.993 
Body weight (kg) 74.62 ± 15.31 74.89 ± 13.28 0.962 
Body length (m) 177.96 ± 9.20 176.62 ± 8.60 0.703 
Baecke-score 8.55 ± 1.25 8.62 ± 1.34 0.896 
SD – standard deviation 
LBP – low back pain 
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Table 3: Means (SD) for total and lean muscle CSA, fat CSA and MFI for the LBP and 410 
control group per muscle, adjusted for body side and level 411 
Parameter Muscle 
LBP 
group 
Control 
group 
total muscle CSA MF 41.0 (15.7) 37.5 (19.1) 
 ES 96.1 (14.1) 99.4 (16.2) 
 PS 79.8 (17.6) 73.0 (19.1) 
lean muscle CSA MF 34.6 (12.7) 30.6 (17.5) 
 ES 87.1 (15.1) 89.5 (17.6) 
 PS 75.3 (16.5) 68.8 (19.0) 
fat CSA MF 6.5 (3.6) 6.8 (4.2) 
 ES 8.4 (2.1) 10.0 (2.9) 
 PS 4.6 (1.7) 4.2 (2.8) 
MFI MF 18.4 (6.4) 14.0 (2.6) 
 ES 23.9 (6.1) 20.7 (2.5) 
 PS 25.9 (5.9) 21.9 (2.9) 
SD – standard deviation 
LBP – Low back pain 
CSA – cross-sectional area ; MFI – muscle-fat-index 
MF – multifidus; ES – erector spinae; PS - psoas 
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Table 4: Means (SD) for total and lean muscle CSA, fat CSA and MFI on the previously 412 
painful (Pain) and non-painful (No Pain) side in the LBP group per muscle, adjusted 413 
for body side and level 414 
Parameter Muscle No Pain Pain 
total muscle CSA MF 40.9 (15.7) 41.0 (15.5) 
 ES 96.1 (14.0) 96.0 (13.8) 
 PS 81.5 (17.7) 78.2 (17.5) 
lean muscle CSA MF 34.9 (12.6) 34.3 (12.4) 
 ES 87.0 (15.1) 87.3 (14.9) 
 PS 77.6 (16.6) 72.9 (16.4) 
fat CSA MF 6.3 (3.6) 6.7 (3.7) 
 ES 8.6 (2.0) 8.2 (2.1) 
 PS 4.0 (1.6) 5.2 (1.7) 
MFI MF 18.8 (6.3) 18.1 (6.8) 
 ES 22.1(5.9) 25.7 (6.5) 
 PS 27.0 (6.0) 24.9 (6.1) 
SD – standard deviation 
LBP – Low back pain 
CSA – cross-sectional area ; MFI – muscle-fat-index 
MF – multifidus; ES – erector spinae; PS - psoas 
 415 
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ILLUSTRATIONS 416 
Figure 1: Axial slice at the level of L4 upper endplate. Lean cross-sectional area (CSA) 417 
is illustrated on the left; total CSA is illustrated on the right for multifidus, erector 418 
spinae and psoas in a representative participant from the LBP group. 419 
 420 
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Figure 2: Normalized lean and fat cross-sectional area (CSA, %) per muscle (MF = 421 
multifidus, ES = erector spinae, PS = psoas) for low back pain (LBP) and control (CON) 422 
group. Total CSA is represented as the sum of lean and fat CSA. 423 
 424 
28 
 
Figure 3: Muscle-fat-index per lumbar level for low back pain (LBP) and control (CON) 425 
group. * p<0.05 426 
 427 
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